A multivariable Cox regression analysis was performed to evaluate the predictive value of tumor PD-L1 expression by physician’s quantification for the survival outcome of anti-PD-1-based ICB therapy in metastatic melanoma. This evidence concerns the gene CD274 and metastatic melanoma.